LARGO, Fla., Dec. 3, 2009 (GLOBE NEWSWIRE) -- GeoPharma, Inc. (Nasdaq:GORX) (the "Company") announced today it received a NASDAQ Staff Deficiency Letter on November 25th, 2009 indicating that the Company does not comply with the Minimum Stockholders' Equity requirement for continued listing set forth in NASDAQ Listing Rule 5550(b)(1).
